The former boss of GKN stands to make £9 million from a takeover of the car and plane parts manufacturer.Nigel Stein – who left the FTSE 100 company last month after more than five years in charge – could receive the windfall from his shares after turnaround specialist Melrose Industries made a £7 billion bid for the business.GKN’s shares jumped 26 per cent on Friday following the approach. They had previously been slowly recovering from a shock profit warning in October which Stein said had left him feeling ‘mugged’.GKN, which traces its roots back to 1759, rejected the bid which it described as ‘opportunistic’ because the terms ‘fundamentally undervalue’ the business.But Melrose, a London-listed firm with a reputation for turning around ailing industrial businesses, is expected to push ahead with a hostile bid.In response, GKN laid out plans to split its automotive business, which makes driveshafts for Ford and Volkswagen cars, and its aerospace arm, which makes parts for Boeing.Investors have long been calling for their separation.Melrose’s offer is partly in cash but mainly in shares. It means Stein would cash in £1.7 million from a sale at the amount offered and would be sitting on another £7 million in shares in the merged company.Liberal Democrat leader Sir Vince Cable said he would ask Business Secretary Greg Clark to intervene, arguing that the takeover would be a ‘massive blow to our industrial strategy’.
The class of drugs that Levitra, Viagra, Stendra, and Cialis belong to are called PDE5 inhibitors. They work by relaxing tight blood vessels, allowing more blood to surge into the penis and cause an erection, says Gregory Bales, M.D., an associate professor of urology at the University of Chicago.
The little pills do the trick for more than two-thirds of men with Viagra protects the heart (ED). They also work for guys who simply need them for a short time to get their “confidence back,” says Michael Eisenberg, M.D., director of male reproductive medicine and surgery at Stanford University.